Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 24 (ELOCP24)
- Target
- ELOCP24
- Molecular classification
- Other (Pseudogene)
01
Overview
Elongin C pseudogene 24 (ELOCP24, also known as TCEB1P24 or TCEB1P25) is classified as a pseudogene, specifically a non-protein-coding gene that comprises regions similar to those encoding elongin C, a regulatory component of the transcription factor B (SIII) complex. Unlike the functional elongin C gene (ELOC), which forms part of a protein complex essential for transcriptional elongation and proteasomal targeting in cells, ELOCP24 does not encode a protein and has no known biological activity, molecular function, or disease association. There are no drugs known to interact with this pseudogene, and it is not considered a therapeutic target.
- Other names
- TCEB1P24TCEB1P25transcription elongation factor B (SIII), polypeptide 1 pseudogene 24transcription elongation factor B (SIII), polypeptide 1 pseudogene 25transcription elongation factor B subunit 1 pseudogene 24
02
Mechanism of action
None
03
Biological functions
Other (No known biological function; not a protein-coding gene)
04
Disease associations
None known (no known disease association)
Beyond the preview
Go deeper on Elongin C pseudogene 24 (ELOCP24).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elongin C pseudogene 24 (ELOCP24).